Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin + Pioglitazone Extension in T2DM
NCT00138554Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Nov 2004; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00138554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138554.